Dear Investor,
On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.
This revolutionary new kind of treatment will not just change medicine -
It has the potential to eliminate genetic disease from our species.
If that sounds like science fiction, consider this -
| • | | The Nobel Prize Committee is calling it "The Holy Grail of Medicine" | | | | • | | The Wall Street Journal reports the company is "transforming medicine." | | | | • | | 60 Minutes reports the company is "revolutionizing the search for new drugs." | | | And the biggest drug companies have rushed to invest over a $1 billion in the past year alone -
Juno Pharma invested $700 million.
Glaxo SmithKline invested $350 million.
Johnson and Johnson invested $292 million.
That's on top of the $120 million Bill Gates and Google Ventures already invested into this.
The list goes on and on...
Never before has so much money invested in a new treatment so quickly.
And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.
Investor's Business Daily estimates the market is worth at least $75 billion market.
But right now, its stock price is just a tiny fraction of that size.
Our research proves that anyone who gets in today could turn every $1, 00 into $1.57 million (or more)!
That's if the company doesn't get taken over for fast 300% gains first.
CLICK HERE to see how you can profit from this rare opportunity>>>
Sincerely,
Dylan Jovine
Behind the Markets
"The Buck Stops Here"
| | From time to time your free Options Profits Daily newsletter subscription is supplemented by paid sponsorships, like the one above. Please read all disclaimers. Rest assured that your information was not shared with this sponsor. Please note that Options Profits Daily has not independently reviewed the validity of the claims or statements contained within this sponsorship, and we are not responsible for any errors or omissions.
Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors featured on this site may own securities mentioned in their articles and not disclose this information. Options Profits Daily does not endorse any investing or trading products or newsletters advertised in this email or on our web site. Please be sure to read our
Go here to get more information from |  | | | | | |
No comments:
Post a Comment